Netherlands Pharmaceutical Capex Project Reporting Package 2016 – Research and Markets
May 10, 2016 | By Business Wire News
DUBLIN
Research and Markets has announced the addition of the “Pharmaceutical Capex Project Reporting Package – Netherlands” report to their offering.
This Pharmaceutical capex project reporting extends throughout the Netherlands and covers all aspects of capital investment in product development and manufacturing across the industry, including primary, secondary, biotech, OTC, medical devices and personal care products.
Projects included within the package are all scheduled to enter the Procurement Phase during 2016 and range from plant upgrades and modifications to expansions and complete new builds, all with a breadth of scope to include a wide range of process equipment and associated services. The package’s focus on the processing aspects of projects also includes the production environment and ancillary services such as cleanrooms, HVAC, utilities, effluent treatment and laboratories.
One of the most important features of this project reporting is the inclusion of key decision makers which includes contacts with roles encompassing:
– External consultants
– Technology providers
– Design
– Engineering
– EPC contractors
– Equipment specification & selection
– Procurement
– Planning
– Project management
– Operations management
Within this package there are 71 project reports which include:
– Capital Expenditure > 1m
– Scheduled to enter procurement phase during 2016
– Project Types:
– – New Builds
– – Expansions
– – Upgrades
– – Modifications
– Facility Types
– – Manufacturing Processes
– – Product Development / R&D
– – Controlled Storage
– – Site Utilities
Key Topics Covered:
1. Company Information
– Name
– Address
– Phone
– Web Site
2. Project Information
– Sensitivity
– Description
– Product Type
– Project Location
– Project Region
– Value
– Status
3. Contacts
4. Schedule
5. Notes
Companies Mentioned
– Abbott Biologicals BV
– Abbott Healthcare Products BV
– Abbott Laboratories BV
– Alfasan International BV
– Aspen Oss BV
– Basic Pharma Manufacturing BV
– Bilthoven Biologicals BV
– Dechra Pharmaceuticals BV
– Famar Netherlands BV
– FrieslandCampina DMV BV
– Genencor International Belgium BVBA
– Janssen Biologics BV
– Janssen Pharmaceutica NV
– Kepro NL BV
– MSD Animal Health
– MSD Oss BV
– Mead Johnson BV
– MedImmune Pharma BV
– Merck Sharp & Dohme BV
– Nutricia BV
– Nutricia Cuijk BV
– Patheon Biologics NV
– Produlab Pharma Production BV
– SoliPharma BV
– SynCo Bio Partners BV
– Teva Pharmachemie BV
For more information visit http://www.researchandmarkets.com/research/5m6fsx/pharmaceutical
View source version on businesswire.com: http://www.businesswire.com/news/home/20160510005768/en/
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceutical Packaging
